Form 4 for MBIO MUSTANG BIO, INC.
Accepted 2023-04-03 00:00:00 ET · period of report 2022-07-29 · accession 0001104659-23-040927 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-03 | 2022-07-29 | MBIO | ZELEFSKY MICHAEL J | Dir | A - Grant | $0.00 | +71.7K | 175.9K | +69% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK, PAR VALUE $0.0001 | 2022-07-29 | A | A | 71,664 | $0.00 | 175,861 | D | — | — | (F1) The Reporting Person was granted 71,664 restricted shares pursuant to the Issuer's 2016 Incentive Plan on July 29, 2022. The shares will vest on June 17, 2025, subject to the Reporting Person's continued service on the Issuer's board on such date. (F2) Includes restricted share units, which vest over various time periods. |